medigraphic.com
SPANISH

Evidencia Médica e Investigación en Salud

ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2008, Number 1

<< Back Next >>

Evid Med Invest Salud 2008; 1 (1)

Urological complications: Incidence, types and management in 676 renal transplantations. Experience of the Ignacio Chávez National Institute of Cardiology

Ojeda-Alcalá Á Aburto-Morales S, Soel-Encalada J, Rodríguez-Castellanos F, Mendoza-Valdez A, Franco-Guevara M, Mancilla-Urrea E
Full text How to cite this article

Language: Spanish
References: 8
Page: 9-14
PDF size: 292.35 Kb.


Key words:

Urological Complications, renal transplant, renaltransplantation, incidence.

ABSTRACT

Objective: To know the incidence, types and management of urological complications. Methods: A retrospective and descriptive study; the files of 676 patients who had a renal transplantation from June 1968 to February 2005 were studied. The analyzed variables were: age, sex, diagnosis of renal failure, HLA, CMV, donor type, ischemia times, type of ureteroneocystostomy, immunosuppression, type and time of presentation of the complication, management, diagnostic methods, renal function at 6 and 12 months with serum creatinine, histopathology, complications and infections. Results: Of the 676 transplantations carried out, 11.06% presented urological complications, the most frequent being urinary fistula. The treatment was with a ureteral reimplantation plus the use of a double-J stent, uretero-uretero anastomosis, pyelo-uretero anastomosis, fistula closure plus double-J stent, nephrostomas, cystorrhaphy, Ureteral splinting with Nelaton catheter, conservative treatment using Foley’s catheter, Epiplon patch and the of freeing the ureter. There were post-surgical infections in 33 of the transplants. The histopathology showed damage due to ischemia. The average creatinine level at 6 and 12 months post-treatment was 1.6 mg/dl and 1.63 mg/dl, respectively. Conclusion: The urological complications continue to accompany renal transplantation for all types of donor. Urinary fistulas continue to be the most common complication, and within these, the most common is that located in the zone of the neocystoureteroanastomosis. Early surgical treatment is the best surgical alternative.


REFERENCES

  1. M Whang, S Geffner, S Baimeedi, L Bonomini, and S Mulgaonkar. Urologic Complications in Over 1000 Kidney Transplants Performed at The Saint Barnabas Healthcare System. Transplantatión Proceedings, 35, 1375- 1377 (2003).

  2. Georges Karam, Fréderic Maillet, Sophie Parant, Jean-Paul Soulillou, and Magali Giral-Classe. Ureteral Necrosis after Kidney Transplantation: Risk factors and Impact on Graft and Patient Survival. Transplantation, volume 78, number 5, September 15, 2004.

  3. A J Figueiredo, B A Parada, MFX Cunha, AJ Mota, and AJ Furtado. Ureteral complications: Analysis of Risk Factors in 1000 Renal Transplants. Transplantation Proceedings, 35, 1087-1088 (2003).

  4. R B Khauli. Efficacy of Extravesical Ureteral Reimplant and Routine Stenting in Renal Transplantation. Transplantation Proceedings, 35 2664 (2003).

  5. C Reek, M Noster, D Burmeister, JM Wolff, and H Seiter. Urological Complications of Renal Transplantation: A series of 900 Cases. Transplantation Proceedings, 35, 2106-2107 (2003).

  6. GM Danovitch. Trasplante Renal. UCLA School of Medicine, Los Angeles, California. 2002.

  7. R Taghavi, RM Zafarghandi, and MR Darabi. Renal Transplantatión and Ureteroneocystostomy (Living and Cadaveric Donor). Transplantatión Proceedings, 35 2660-2661 (2003).

  8. RE Power, DP Hickey, and DM Little. Urological Evaluation Prior to Renal Transplantation. Transplantation Proceedings, 36, 2962-2967 (2004).




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Evid Med Invest Salud. 2008;1